<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Investing in Oncology: 3 Cancer Stocks With Promising Pipelines</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Investing in Oncology: 3 Cancer Stocks With Promising Pipelines</h1>
  <ul>
<li>Preliminary data from monotherapy expansion cohorts of the study are expected in the second half of 2025 and in 2026.</li>
<li>Relay Therapeutics has a Zacks Rank #2 (Buy).</li>
<li>Today, you can download 7 Best Stocks for the Next 30 Days.</li>
<li>You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.</li>
<li>As per the American Cancer Society, the United States alone is expected to see 2,041,910 new cancer cases and 618,120 cancer-related deaths in 2025.</li>
<li>A phase I study has been initiated in patients with R/M HNSCC and other advanced solid tumors, with preliminary data expected in the second half of 2025.</li>
<li>Explore 30 cutting-edge investment themes with Zacks Thematic Screensand uncover your next big opportunity.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/investing-oncology-3-cancer-stocks-134200392.html">Source</a> · 2025-09-08T13:42:00+00:00</p>
</body>
</html>